MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bmcl.2016.10.085

Медицинская библиотека · Bioorganic & medicinal chemistry letters · 2016

Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.

Xu Jiayi, Lin Songnian, Myers Robert W, Addona George, Berger Joel P, Campbell Brian, Chen Hsuan-Shen, Chen Zhesheng, Eiermann George J, Elowe Nadine H, Farrer Brian T, Feng Wen, Fu Qinghong, Kats-Kagan Roman, Kavana Michael, Malkani Sunita, McMasters Daniel R, Mitra Kaushik, Pachanski Michele J, Tong Xinchun, Trujillo Maria E, Xu Libo, Zhang Bei, Zhang Fengqi, Zhang Rui, Parmee Emma R

СтатьяПеревод в очереди

Аннотация

Glucokinase (GK, hexokinase IV) is a unique hexokinase that plays a central role in mammalian glucose homeostasis. Glucose phosphorylation by GK in the pancreatic β-cell is the rate-limiting step that controls glucose-stimulated insulin secretion. Similarly, GK-mediated glucose phosphorylation in hepatocytes plays a major role in increasing hepatic glucose uptake and metabolism and possibly lowering hepatic glucose output. Small molecule GK activators (GKAs) have been identified that increase enzyme activity by binding to an allosteric site. GKAs offer a novel approach for the treatment of Type 2 Diabetes Mellitus (T2DM) and as such have garnered much attention. We now report the design, synthesis, and biological evaluation of a novel series of 2,5,6-trisubstituted indole derivatives that act as highly potent GKAs. Among them, Compound 1 was found to possess high in vitro potency, excellent physicochemical properties, and good pharmacokinetic profile in rodents. Oral administration of Compound 1 at doses as low as 0.03mg/kg led to robust blood glucose lowering efficacy in 3week high fat diet-fed mice.

Для цитирования: Xu Jiayi, Lin Songnian, Myers Robert W, Addona George, Berger Joel P, Campbell Brian, Chen Hsuan-Shen, Chen Zhesheng, Eiermann George J, Elowe Nadine H, Farrer Brian T, Feng Wen, Fu Qinghong, Kats-Kagan Roman, Kavana Michael, Malkani Sunita, McMasters Daniel R, Mitra Kaushik, Pachanski Michele J, Tong Xinchun, Trujillo Maria E, Xu Libo, Zhang Bei, Zhang Fengqi, Zhang Rui, Parmee Emma R. Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.. Bioorganic & medicinal chemistry letters. 2016. DOI: 10.1016/j.bmcl.2016.10.085.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.